Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer
Amanda Psyrri(National and Kapodistrian University of Athens), George Fountzilas(Hellenic Cooperative Oncology Group), Dimitrios Krikelis(Aristotle University of Thessaloniki), Nikolaos Angouridakis(Aristotle University of Thessaloniki), Ilias Karasmanis(Aristotle University of Thessaloniki), Konstantinos Markou(Aristotle University of Thessaloniki), Vassiliki Kotoula(Aristotle University of Thessaloniki), Zoi Alexopoulou(Datamed Systems Integration (Greece)), Georgia Karayannopoulou(Aristotle University of Thessaloniki), Elena Fountzilas(St. Luke's Hospital), Angelos Nikolaou(Aristotle University of Thessaloniki), Mattheos Bobos(Aristotle University of Thessaloniki), Konstantine T. Kalogeras(Aristotle University of Thessaloniki), Despina Televantou(Aristotle University of Thessaloniki)
Cited by 27
Related Papers
Review of precision cancer medicine: Evolution of the treatment paradigm
|Cancer Treatment Reviews|2020|747
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2021|618
Gene Expression Profile of <i>BRCA</i>ness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
|Journal of Clinical Oncology|2010|488
Clinical trial design in the era of precision medicine
|Genome Medicine|2022|279
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
|Cancer Research|2011|266